Dr. Jeremy Dustin Clark, MD

Dr. Clark practices at Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky.

Dr. Clark's NPI, 1073838850, was assigned on April 5, 2010. Dr. Clark graduated from University Of Louisville School Of Medicine in 2010. Dr. Clark holds Kentucky license 47098.

Dr. Clark's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD, at 200 Abraham Flexner Way, Louisville, KY 40202.

Dr. Clark's primary practice is Jewish Hospital and St Mary's Healthcare - HOPD in Louisville, Kentucky. Dr. Clark is also affiliated with UofL Health - Jewish Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. Clark to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clark practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Clark's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Clark is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Clark's licenses on file in 2 states: Kentucky and Indiana.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation and vision problems among the conditions Dr. Clark treats.

CMS data shows 767 Medicare services from Dr. Clark across 13 procedure codes in 2024, for 351 Medicare patients. Medicare paid $87,263 for them.

CMS counts 351 Medicare patients who saw Dr. Clark in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.15, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clark's median patient age at 71, with 64% women.

In 2024, Dr. Clark wrote 537 Medicare Part D claims for 232 patients. 95% of them were for generic drugs. CMS names the drug for 454 of them, across 4 drugs with 11 or more claims each, at $3,446 in total drug cost. In 2023, CMS named 419 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Clark for performance year 2024, reported as part of a group. Dr. Clark accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of melanoma (skin cancer) excision by Dr. Clark, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 30 papers to Dr. Clark, published from 2010 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Ophthalmologic Surgical Procedures, Orbit and Tomography, X-Ray Computed. Dr. Clark has published most often in Orbit. Dr. Clark's most frequent co-authors are Christopher J. Compton, MD, William R. Nunery, MD and Jason Aaron Sokol, MD.

CMS Open Payments shows 251 general payments to Dr. Clark from 20 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Horizon Pharma plc paid the most, $76,163.

Dr. Clark graduated from University Of Louisville School Of Medicine in 2010. Dr. Clark is a member of AAO, Kentucky Academy of Eye Physicians and Surgeons and Louisville Academy of Ophthalmology.

Dr. Clark is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.